Medical Technology

John Burt
Tue, 25/06/2019 - 07:00
Coventry, UK, 25th June 2019 / Sciad Newswire / Medherant Limited (“Medherant”), the clinical-stage company developing
Sat, 25/05/2019 - 06:30
Potential New Treatment for Acute Heart Failure Presented at the Heart Failure 2019 Congress  TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system 
Bio Integrates May 2019
Fri, 24/05/2019 - 11:30
London, UK, 24th May 2019 / Sciad Newswire / Following the continued success of Pharma Integrates, the inaugural
Tue, 21/05/2019 - 15:15
Coventry, UK, 21st May 2019 / Sciad Newswire / Medherant Limited (“Medherant”), the clinical-stage developer of innovat
Tue, 21/05/2019 - 07:00
London, UK, 21st May 2019 / Sciad Newswire / The £27m UK Innovation & Science Seed Fund (UKI2S) and In
Thu, 24/01/2019 - 13:00
Call for the world’s greatest minds to tackle the world’s biggest killers  The British Heart Foundation’s Big Beat Challenge is now accepting proposals
Mon, 14/01/2019 - 07:30
Bournemouth, UK and Newark, CA, USA, 14th January 2019 / Sciad Newswire / Solentim, a global leader in cell line developmen
Mon, 17/12/2018 - 08:30
London, UK, 17th December 2018 / Sciad Newswire / In January, the largest genomics event in the UK will return to London for the fourth time.
Tue, 27/11/2018 - 08:30
Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their lives.1 Indeed, with Men’s Health Awareness Month underway, the importance of tackling this prevalent diseas
Solentim
Fri, 16/11/2018 - 12:48
Solentim named as one of the top 50 fastest growing UK technologies companies of 2018

Pages